文献速递高血压

中高危肺栓塞联合导管介入治疗与标准治疗对照的随机预试验

A Randomized Pilot Trial Comparing Combined Catheter‐Interventional Treatment Versus Standard of Care in Intermediate High‐Risk Pulmonary Embolism
RSS 订阅 · Catheterization and Cardiovascular Interventions · 2026-10-14

24小时后联合导管介入治疗在复合临床终点和右室/左室比值改善上均优于对照组,住院死亡和出血安全性相似。结果支持进一步开展更大规模试验验证。

要点

  • 联合导管介入治疗24小时即改善复合临床终点和右室/左室比值
  • 联合导管介入治疗与常规治疗在住院死亡和出血方面安全性相似
  • 该预试验样本量小,疗效需更大规模试验进一步证实

核心结论

  • 在中高危肺栓塞患者中,联合导管介入治疗相比常规肺栓塞治疗显示有效且安全

研究设计与样本

  • 联合导管介入治疗由局部纤溶和机械取栓组成,对照组接受常规指南指导治疗

主要发现

  • 24小时后联合导管介入组复合临床终点改善0.02±0.01,对照组为-0.01±0.01,组间比较p<0.001
  • 24小时后联合导管介入组右室/左室比值下降0.3±0.2,对照组为-0.1±0.1,组间比较p=0.02
  • 住院死亡和出血等安全性结局在两组间相似

关键数值与推荐

  • 复合临床终点由收缩压除以心率及呼吸频率构成
  • 右室/左室比值通过经胸超声心动图测量

临床怎么用

  • 对于中高危肺栓塞患者,可考虑局部纤溶联合机械取栓的联合导管介入治疗策略
  • 该策略在24小时内可改善血流动力学相关指标和右室/左室比值

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ABSTRACT Background Catheter-directed treatment of pulmonary artery embolism (PE) is increasingly used worldwide. Numerous devices for mechanical thrombectomy (MT) and local fibrinolysis (LF) have become available over recent years. While various studies show safety and efficacy for either MT or LF, little is known about the combination of both treatment modalities. Aims This open-label, single-center, randomized controlled pilot trial aimed to investigate the treatment effect size and safety of a combined catheter-interventional treatment (CCIT) approach for PE, consisting of LF and MT in comparison to conventional guideline-directed therapy. Methods Twenty patients with intermediate-high risk PE were randomized 2:1 to CCIT or control. The two co-primary endpoints were the difference in (1) a combined clinical endpoint (consisting of systolic blood pressure over heart rate, and respiratory rate) and (2) right-to-left ventricular (RV/LV)-ratio from a transthoracic echocardiogram between the two groups 24 h after randomization. Results After 24 h, the combined clinical endpoint improved by 0.02 ± 0.01 in the CCIT group, whereas no improvement was observed in the control group (−0.01 ± 0.01, p < 0.001 for between-group comparison). RV/LV-ratio was reduced by 0.3 ± 0.2 in the CCIT-group and remained unchanged in the control group (−0.1 ± 0.1, p = 0.02 for between-group comparison). Safety outcomes, including in-hospital mortality and bleeding, were similar between the two treatment groups. Conclusion In this pilot study, CCIT of intermediate-high risk PE was found to be effective and safe in comparison to conventional PE treatment. These findings warrant confirmation in larger-scale trials.

来源:Catheterization and Cardiovascular Interventions,查看原文。版权归原作者所有。

引用

  1. Catheterization and Cardiovascular Interventions:A Randomized Pilot Trial Comparing Combined Catheter‐Interventional Treatment Versus Standard of Care in Intermediate High‐Risk Pulmonary Embolism

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。